shortagewatch

Home / Genito-urinary system and sex hormones / Medroxyprogesterone and Estrogen

ATC G03FA12 · Progestogens and Estrogens, Fixed Combinations

Medroxyprogesterone and Estrogen shortage

As of 2 Nov 2026, Medroxyprogesterone and Estrogen has a reported shortage in 1 of the 16 countries we track (Czechia), covering 1 product from 1 company.

Countries1/16
Products1packs or presentations
Companies11 listed
Short since11 Oct 202622 days ago
Earliest return15 Nov 2026company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechia1 product shortNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

Czechia
INDIVINA 2MG/5MG 2MG/5MG TBL NOB 3X28INDIVINA 2MG/5MG 2MG/5MG TBL NOB 3X28today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Orion1 ORNBV

Listed: Orion ORNBV · Nasdaq Helsinki

Compared with similar medicines

ATC group G03FA · Progestogens and Estrogens, Fixed Combinations
Drospirenone and Estrogen2/16Norethisterone and Estrogen2/16Progesterone and Estrogen2/16Medroxyprogesterone and Estrogen1/16

Affected products

CountryProductCompanySinceExpected backReason
CZINDIVINA 2MG/5MG 2MG/5MG TBL NOB 3X28Orion Corporation, Espoo11 Oct 202615 Nov 2026Manufacturing problem
Výrobní důvody

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.